Matthias Mueller – a:care Congress – Acare HCP Global
Skip to content
Home > Congress > Speakers > Dr. Matthias Mueller MD MSc

Dr. Matthias Mueller MD MSc

Switzerland

Dr. Matthias Mueller MD MSc, Divisional Vice President Innovation and Development, Abbott’s Established Pharmaceuticals business

Matthias Mueller heads Innovation and Development at Abbott’s Established Pharmaceuticals business. He leads a team of more than 1500 scientists and specialists worldwide that help deliver insight-driven, differentiated innovations to people in emerging countries.

Matthias has 20+ years of medical, clinical, research, and leadership expertise, overseeing several departments over his career at leading healthcare companies. He has led teams in Product Design and Development, Clinical Development and Operations, Pharmacovigilance and Patient Safety, and Regulatory and Medical Affairs.

A medical doctor by education, Matthias completed medical school, his residency, and his fellowship in the Department of Neurology at the University of Heidelberg, Germany, with a clinical and research focus on stroke and its prevention, epilepsy, and multiple sclerosis. Matthias specialized in Pharmaceutical Medicine at the University of Surrey, UK.

As a healthcare professional, he aims to make a meaningful difference in people’s lives so that more people in emerging countries can get and stay healthy.

Share this post

Read more on this topic

IOF endorses a:care to strengthen medication adherence in osteoporosis…

Mediterranean diet & cardiometabolic health: How to improve patient adherence

Improving medication adherence: Abbott's commitment to better health

A:CARE Congress 2024 proceedings published in BMC proceedings

Tackling medication adherence barriers: Improve adherence, reduce societal…

Bones, beliefs, and behavior: Tackling the adherence gap in osteoporosis care

Supporting adherence: Leveraging the power of family and peers

The impact of health literacy on medication adherence

Rx for change: Addressing social determinants to improve medication adherence

Should patients be paid to take their treatment?

Navigating the world of biosimilars for better health outcomes and…

The hidden challenge of non-adherence in kidney transplantation